Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder.

Hyunjin KimEun-Jae LeeSeungmi KimLyn-Kyung ChoiHyun-Ji KimHye Weon KimKyuyoon ChungDayoung SeoSeongshin MoonKwang-Kuk KimYoung-Min Lim

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

Among NfL, GFAP, and GFAP/NfL, serum GFAP might be the most appropriate for monitoring NMOSD longitudinally, which warrants future confirming studies.

Keyphrases

spectrum disorder
current status
cross sectional